Skip to main content
Fig. 4 | BMC Complementary Medicine and Therapies

Fig. 4

From: Afzelin induces immunogenic cell death against lung cancer by targeting NQO2

Fig. 4

Afzelin inhibits proliferation and promotes apoptosis of lung cancer cells via NQO2. A NQO2 protein and B its mRNA expression are shown. The NQO2 protein expression (C), proliferation (D), and apoptosis (E) of A549 and H1299 cells is visible. *P < 0.05, **P < 0.01, ***P < 0.001 vs. control group. #P < 0.05, ##P < 0.01 vs. Afzelin plus Vector group

Back to article page